1. Management of hemorrhage complicated by novel oral anticoagulants in the emergency department: case report from the northwestern emergency medicine residency.
- Author
-
Kiraly A, Lyden A, Periyanayagam U, Chan J, and Pang PS
- Subjects
- Aged, Aged, 80 and over, Aneurysm, Ruptured complications, Aneurysm, Ruptured diagnosis, Aneurysm, Ruptured therapy, Anticoagulants therapeutic use, Benzimidazoles therapeutic use, Combined Modality Therapy, Dabigatran, Emergency Service, Hospital, Hemoperitoneum diagnosis, Hemoperitoneum etiology, Hemoperitoneum therapy, Humans, Iliac Aneurysm complications, Iliac Aneurysm diagnosis, Iliac Aneurysm therapy, Male, Morpholines therapeutic use, Rivaroxaban, Subarachnoid Hemorrhage diagnosis, Subarachnoid Hemorrhage therapy, Thiophenes therapeutic use, Thromboembolism prevention & control, beta-Alanine adverse effects, beta-Alanine therapeutic use, Anticoagulants adverse effects, Benzimidazoles adverse effects, Blood Coagulation Factors therapeutic use, Hemoperitoneum drug therapy, Hemostatic Techniques, Morpholines adverse effects, Subarachnoid Hemorrhage drug therapy, Thiophenes adverse effects, beta-Alanine analogs & derivatives
- Abstract
Anticoagulation has long complicated the care of hemorrhage in the emergency department and other acute care settings. With the advent of novel anticoagulants such as direct thrombin inhibitors and direct factor Xa inhibitors, the absence of any direct antidote for these medications presents new and difficult challenges in the management of hemorrhagic complications in these patients. We present 2 cases of patients with hemorrhagic complications taking novel oral anticoagulants, their management, and outcomes.
- Published
- 2013
- Full Text
- View/download PDF